MedBen Blog

Keeping You Informed.
get started

Health Care AI Offers Promise and Problems

Expanding use of generative artificial intelligence (AI) in health care has sparked talk of its possibilities while raising ethical questions. Healthcare Dive recently examined generative AI's potential, both positive and negative. From the article: "Generative AI is...

read more

The REAL End of the COVID-19 National Health Emergency

You may have read that on April 10, President Biden signed House Joint Resolution 7, immediately terminating the national health emergency related to the COVID-19 pandemic under the National Emergencies Act. You also may recall that earlier this year, the Biden...

read more

Biosimilars vs. Generics: What’s the Difference?

Much like generics are lower-cost equivalents of more expensive drugs, so too are biosimilars. But there's a notable distinction between the two. Generics contain the exact same active ingredients as their brand-name counterparts and are usually synthesized from...

read more

Coming Soon… The 2023 Client Report!

In the upcoming 2023 MedBen Client Report, we'll be looking at some of the issues that affected our clients last year, and the ways we worked with them to find successful solutions to preserve or improve their benefits. "With health care inflation expected to double...

read more

Get Actionable Insights with MedBen Analytics Reporting

MedBen Analytics offers a variety of customizable, downloadable reports to help you make informed decisions about changes to your plan. While there are dozens available to choose from, the most popular reports used by MedBen clients include: Utilization Metrics....

read more

High Blood Pressure Linked to Dementia, Study Finds

A new study serves as a reminder that wellness promotes a healthy mind as well as a healthy body. According to an international team of researchers, there is a direct link between high blood pressure and dementia. Using information from genetic and imaging data and...

read more

Drugmakers (Kind of) Lower Insulin Costs

Earlier this month, drug manufacturer Eli Lilly announced that it cutting the cost of two of its prescription brand insulins, Humalog and Humulin, by 70%, and capping out-of-pocket costs for privately insured patients at $35 a month. Competing drugmakers Novo Nordisk...

read more

Ensuring Health Privacy is a MedBen Priority

Following news that digital health companies GoodRx and BetterHelp shared sensitive user information with advertisers, the Federal Trade Commission (FTC) has requested funds for ensuring health privacy in its 2024 budget proposal. The budget request sites merger...

read more